Report Detail

Request for Sample of this report

Other Global IVD Infectious Diseases Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3693910
    • |
  • 12 June, 2024
    • |
  • Global
    • |
  • 138 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global IVD Infectious Diseases market size was valued at USD 17100 million in 2023 and is forecast to a readjusted size of USD 21950 million by 2030 with a CAGR of 3.6% during review period.
In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
The Global Info Research report includes an overview of the development of the IVD Infectious Diseases industry chain, the market status of Clinical Laboratories (Immunochemistry, Molecular Diagnostics), Diagnostic Centers (Immunochemistry, Molecular Diagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IVD Infectious Diseases.
Regionally, the report analyzes the IVD Infectious Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IVD Infectious Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IVD Infectious Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IVD Infectious Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunochemistry, Molecular Diagnostics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IVD Infectious Diseases market.
Regional Analysis: The report involves examining the IVD Infectious Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IVD Infectious Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IVD Infectious Diseases:
Company Analysis: Report covers individual IVD Infectious Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IVD Infectious Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Laboratories, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to IVD Infectious Diseases. It assesses the current state, advancements, and potential future developments in IVD Infectious Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IVD Infectious Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IVD Infectious Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Immunochemistry
Molecular Diagnostics
Market segment by Application
Clinical Laboratories
Diagnostic Centers
Market segment by players, this report covers
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Abbott
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe IVD Infectious Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVD Infectious Diseases, with revenue, gross margin and global market share of IVD Infectious Diseases from 2019 to 2024.
Chapter 3, the IVD Infectious Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IVD Infectious Diseases market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVD Infectious Diseases.
Chapter 13, to describe IVD Infectious Diseases research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of IVD Infectious Diseases
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of IVD Infectious Diseases by Type
    • 1.3.1 Overview: Global IVD Infectious Diseases Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global IVD Infectious Diseases Consumption Value Market Share by Type in 2023
    • 1.3.3 Immunochemistry
    • 1.3.4 Molecular Diagnostics
  • 1.4 Global IVD Infectious Diseases Market by Application
    • 1.4.1 Overview: Global IVD Infectious Diseases Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Clinical Laboratories
    • 1.4.3 Diagnostic Centers
  • 1.5 Global IVD Infectious Diseases Market Size & Forecast
  • 1.6 Global IVD Infectious Diseases Market Size and Forecast by Region
    • 1.6.1 Global IVD Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global IVD Infectious Diseases Market Size by Region, (2019-2030)
    • 1.6.3 North America IVD Infectious Diseases Market Size and Prospect (2019-2030)
    • 1.6.4 Europe IVD Infectious Diseases Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific IVD Infectious Diseases Market Size and Prospect (2019-2030)
    • 1.6.6 South America IVD Infectious Diseases Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa IVD Infectious Diseases Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 BD
    • 2.1.1 BD Details
    • 2.1.2 BD Major Business
    • 2.1.3 BD IVD Infectious Diseases Product and Solutions
    • 2.1.4 BD IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 BD Recent Developments and Future Plans
  • 2.2 BioMerieux
    • 2.2.1 BioMerieux Details
    • 2.2.2 BioMerieux Major Business
    • 2.2.3 BioMerieux IVD Infectious Diseases Product and Solutions
    • 2.2.4 BioMerieux IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 BioMerieux Recent Developments and Future Plans
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott IVD Infectious Diseases Product and Solutions
    • 2.3.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Abbott Recent Developments and Future Plans
  • 2.4 Quidel
    • 2.4.1 Quidel Details
    • 2.4.2 Quidel Major Business
    • 2.4.3 Quidel IVD Infectious Diseases Product and Solutions
    • 2.4.4 Quidel IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Quidel Recent Developments and Future Plans
  • 2.5 Gen-Probe
    • 2.5.1 Gen-Probe Details
    • 2.5.2 Gen-Probe Major Business
    • 2.5.3 Gen-Probe IVD Infectious Diseases Product and Solutions
    • 2.5.4 Gen-Probe IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Gen-Probe Recent Developments and Future Plans
  • 2.6 Abbott
    • 2.6.1 Abbott Details
    • 2.6.2 Abbott Major Business
    • 2.6.3 Abbott IVD Infectious Diseases Product and Solutions
    • 2.6.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Abbott Recent Developments and Future Plans
  • 2.7 Danaher
    • 2.7.1 Danaher Details
    • 2.7.2 Danaher Major Business
    • 2.7.3 Danaher IVD Infectious Diseases Product and Solutions
    • 2.7.4 Danaher IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Danaher Recent Developments and Future Plans
  • 2.8 Sysmex
    • 2.8.1 Sysmex Details
    • 2.8.2 Sysmex Major Business
    • 2.8.3 Sysmex IVD Infectious Diseases Product and Solutions
    • 2.8.4 Sysmex IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Sysmex Recent Developments and Future Plans
  • 2.9 Orasure
    • 2.9.1 Orasure Details
    • 2.9.2 Orasure Major Business
    • 2.9.3 Orasure IVD Infectious Diseases Product and Solutions
    • 2.9.4 Orasure IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Orasure Recent Developments and Future Plans
  • 2.10 Hologic
    • 2.10.1 Hologic Details
    • 2.10.2 Hologic Major Business
    • 2.10.3 Hologic IVD Infectious Diseases Product and Solutions
    • 2.10.4 Hologic IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Hologic Recent Developments and Future Plans
  • 2.11 Cepheid
    • 2.11.1 Cepheid Details
    • 2.11.2 Cepheid Major Business
    • 2.11.3 Cepheid IVD Infectious Diseases Product and Solutions
    • 2.11.4 Cepheid IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Cepheid Recent Developments and Future Plans
  • 2.12 Qiagen
    • 2.12.1 Qiagen Details
    • 2.12.2 Qiagen Major Business
    • 2.12.3 Qiagen IVD Infectious Diseases Product and Solutions
    • 2.12.4 Qiagen IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Qiagen Recent Developments and Future Plans
  • 2.13 Roche Diagnostics
    • 2.13.1 Roche Diagnostics Details
    • 2.13.2 Roche Diagnostics Major Business
    • 2.13.3 Roche Diagnostics IVD Infectious Diseases Product and Solutions
    • 2.13.4 Roche Diagnostics IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.14 Siemens Healthcare
    • 2.14.1 Siemens Healthcare Details
    • 2.14.2 Siemens Healthcare Major Business
    • 2.14.3 Siemens Healthcare IVD Infectious Diseases Product and Solutions
    • 2.14.4 Siemens Healthcare IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Siemens Healthcare Recent Developments and Future Plans
  • 2.15 Bio-Rad Laboratories
    • 2.15.1 Bio-Rad Laboratories Details
    • 2.15.2 Bio-Rad Laboratories Major Business
    • 2.15.3 Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions
    • 2.15.4 Bio-Rad Laboratories IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Bio-Rad Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global IVD Infectious Diseases Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of IVD Infectious Diseases by Company Revenue
    • 3.2.2 Top 3 IVD Infectious Diseases Players Market Share in 2023
    • 3.2.3 Top 6 IVD Infectious Diseases Players Market Share in 2023
  • 3.3 IVD Infectious Diseases Market: Overall Company Footprint Analysis
    • 3.3.1 IVD Infectious Diseases Market: Region Footprint
    • 3.3.2 IVD Infectious Diseases Market: Company Product Type Footprint
    • 3.3.3 IVD Infectious Diseases Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global IVD Infectious Diseases Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global IVD Infectious Diseases Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global IVD Infectious Diseases Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global IVD Infectious Diseases Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America IVD Infectious Diseases Consumption Value by Type (2019-2030)
  • 6.2 North America IVD Infectious Diseases Consumption Value by Application (2019-2030)
  • 6.3 North America IVD Infectious Diseases Market Size by Country
    • 6.3.1 North America IVD Infectious Diseases Consumption Value by Country (2019-2030)
    • 6.3.2 United States IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 6.3.3 Canada IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico IVD Infectious Diseases Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe IVD Infectious Diseases Consumption Value by Type (2019-2030)
  • 7.2 Europe IVD Infectious Diseases Consumption Value by Application (2019-2030)
  • 7.3 Europe IVD Infectious Diseases Market Size by Country
    • 7.3.1 Europe IVD Infectious Diseases Consumption Value by Country (2019-2030)
    • 7.3.2 Germany IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 7.3.3 France IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 7.3.5 Russia IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 7.3.6 Italy IVD Infectious Diseases Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific IVD Infectious Diseases Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific IVD Infectious Diseases Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific IVD Infectious Diseases Market Size by Region
    • 8.3.1 Asia-Pacific IVD Infectious Diseases Consumption Value by Region (2019-2030)
    • 8.3.2 China IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 8.3.3 Japan IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 8.3.5 India IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 8.3.7 Australia IVD Infectious Diseases Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America IVD Infectious Diseases Consumption Value by Type (2019-2030)
  • 9.2 South America IVD Infectious Diseases Consumption Value by Application (2019-2030)
  • 9.3 South America IVD Infectious Diseases Market Size by Country
    • 9.3.1 South America IVD Infectious Diseases Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina IVD Infectious Diseases Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa IVD Infectious Diseases Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa IVD Infectious Diseases Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa IVD Infectious Diseases Market Size by Country
    • 10.3.1 Middle East & Africa IVD Infectious Diseases Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia IVD Infectious Diseases Market Size and Forecast (2019-2030)
    • 10.3.4 UAE IVD Infectious Diseases Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 IVD Infectious Diseases Market Drivers
  • 11.2 IVD Infectious Diseases Market Restraints
  • 11.3 IVD Infectious Diseases Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 IVD Infectious Diseases Industry Chain
  • 12.2 IVD Infectious Diseases Upstream Analysis
  • 12.3 IVD Infectious Diseases Midstream Analysis
  • 12.4 IVD Infectious Diseases Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on IVD Infectious Diseases. Industry analysis & Market Report on IVD Infectious Diseases is a syndicated market report, published as Global IVD Infectious Diseases Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of IVD Infectious Diseases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,686.56
    		4,029.84
    		5,373.12
    		3,198.12
    		4,797.18
    		6,396.24
    		529,203.60
    		793,805.40
    		1,058,407.20
    		292,876.80
    		439,315.20
    		585,753.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo